Samsara BioCapital as of Dec. 31, 2022
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 53 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chinook Therapeutics | 29.3 | $135M | 5.2M | 26.20 | |
| Scholar Rock Hldg Corp (SRRK) | 9.0 | $42M | 4.6M | 9.05 | |
| Arcellx Common Stock (ACLX) | 6.4 | $30M | 958k | 30.98 | |
| Graphite Bio | 6.1 | $28M | 8.5M | 3.32 | |
| Verona Pharma Sponsored Ads (VRNA) | 3.9 | $18M | 695k | 26.13 | |
| Rain Therapeutics | 3.9 | $18M | 2.3M | 8.00 | |
| Iveric Bio | 3.7 | $17M | 808k | 21.41 | |
| Nkarta (NKTX) | 3.7 | $17M | 2.9M | 5.99 | |
| Sutro Biopharma (STRO) | 2.9 | $14M | 1.7M | 8.08 | |
| Zymeworks | 2.8 | $13M | 1.6M | 7.86 | |
| Aclaris Therapeutics (ACRS) | 2.4 | $11M | 696k | 15.75 | |
| Hillevax (HLVX) | 2.2 | $10M | 610k | 16.73 | |
| Rhythm Pharmaceuticals (RYTM) | 2.2 | $10M | 345k | 29.12 | |
| Prime Medicine (PRME) | 1.9 | $8.7M | 470k | 18.58 | |
| Pepgen (PEPG) | 1.9 | $8.7M | 651k | 13.37 | |
| Intercept Pharmaceuticals In | 1.7 | $7.9M | 641k | 12.37 | |
| Dice Therapeutics | 1.4 | $6.3M | 203k | 31.20 | |
| Lyra Therapeutics (LYRA) | 1.2 | $5.6M | 1.8M | 3.14 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.1 | $5.3M | 1.7M | 3.10 | |
| Janux Therapeutics (JANX) | 1.0 | $4.7M | 360k | 13.17 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 1.0 | $4.7M | 659k | 7.16 | |
| Immunocore Hldgs Ads (IMCR) | 1.0 | $4.6M | 81k | 57.07 | |
| Tango Therapeutics (TNGX) | 1.0 | $4.6M | 630k | 7.25 | |
| Immatics SHS (IMTX) | 0.9 | $4.3M | 495k | 8.71 | |
| Day One Biopharmaceuticals I (DAWN) | 0.9 | $4.2M | 196k | 21.52 | |
| Alx Oncology Hldgs (ALXO) | 0.6 | $3.0M | 263k | 11.27 | |
| Igm Biosciences (IGMS) | 0.6 | $2.6M | 155k | 17.01 | |
| Io Biotech (IOBT) | 0.5 | $2.3M | 1.0M | 2.30 | |
| Amryt Pharma Sponsored Ads | 0.5 | $2.2M | 305k | 7.30 | |
| Albireo Pharma | 0.5 | $2.2M | 100k | 21.61 | |
| Terns Pharmaceuticals (TERN) | 0.4 | $2.1M | 202k | 10.18 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.4 | $1.7M | 480k | 3.50 | |
| Decibel Therapeutics | 0.4 | $1.6M | 802k | 2.05 | |
| Allakos (ALLK) | 0.3 | $1.4M | 172k | 8.42 | |
| Bolt Biotherapeutics (BOLT) | 0.3 | $1.4M | 1.0M | 1.30 | |
| Instil Bio | 0.2 | $1.1M | 1.8M | 0.63 | |
| Vtv Therapeutics Cl A | 0.2 | $1.1M | 1.6M | 0.66 | |
| Viracta Therapeutics (VIRX) | 0.2 | $1.0M | 690k | 1.46 | |
| Elevation Oncology (ELEV) | 0.2 | $789k | 831k | 0.95 | |
| Equillium (EQ) | 0.1 | $653k | 616k | 1.06 | |
| Springworks Therapeutics (SWTX) | 0.1 | $578k | 22k | 26.01 | |
| Novavax Com New (NVAX) | 0.1 | $459k | 45k | 10.28 | |
| Kala Pharmaceuticals | 0.1 | $459k | 12k | 38.15 | |
| Allovir (ALVR) | 0.1 | $422k | 82k | 5.13 | |
| Aeglea Biotherapeutics | 0.1 | $398k | 884k | 0.45 | |
| Science 37 Holdings | 0.1 | $374k | 900k | 0.42 | |
| Astria Therapeutics (ATXS) | 0.1 | $372k | 25k | 14.89 | |
| Atreca Cl A Com (BCEL) | 0.1 | $318k | 397k | 0.80 | |
| Surrozen | 0.0 | $175k | 300k | 0.58 | |
| Kronos Bio (KRON) | 0.0 | $127k | 78k | 1.62 | |
| Ngm Biopharmaceuticals (NGM) | 0.0 | $69k | 14k | 5.02 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $19k | 133k | 0.14 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $5.5k | 100k | 0.06 |
